设为首页 加入收藏

TOP

DAURISMOTM(glasdegib)tablets, for oral(十五)
2018-11-24 13:52:05 来源: 作者: 【 】 浏览:9304次 评论:0
r feel your heart beating irregularly or fast during treatment with DAURISMO.
The most common side effects of DAURISMO with cytarabine include:
low red blood cell count (anemia)  low platelet count
tiredness  shortness of breath
bleeding  decreased appetite
fever with low white blood cell count
muscle pain
nausea
swelling of arms or legs
changes in taste
pain or sores in your mouth or throat
constipation
rash
DAURISMO may affect fertility in males. Talk to your healthcare provider if this is a concern for you.
These are not all of the possible side effects of DAURISMO.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store DAURISMO?
Store DAURISMO at room temperature between 68°F to 77°F (20°C to 25°C).
Keep DAURISMO and all medicines out of the reach of children.
General information about the safe and effective use of DAURISMO.
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not useDAURISMO for a condition for which it was not prescribed. Do not give DAURISMO to other people, even if they havethe same symptoms that you have. It may harm them. You can ask your healthcare provider or pharmacist for more
information about DAURISMO that is written for health professionals.
What are the ingredients in DAURISMO?
Active ingredient: glasdegib
Inactive ingredients: microcrystalline cellulose, dibasic calcium phosphate anhydrous, sodium starch glycolate, andmagnesium stearate.
Film-coating:
25 mg tablets: Opadry II Yellow (33G120011) containing hypromellose, titanium dioxide, lactose monohydrate,macrogol, triacetin, and iron oxide yellow.
100 mg tablets: Opadry II Beige (33G170003) containing hypromellose, titanium dioxide, lactose monohydrate,macrogol, triacetin, iron oxide yellow, and iron oxide red.
LAB-1285-0.6
For more information, go to www.DAURISMO.com or call 1-800-438-1985.
This Medication Guide has been approved by the U.S. Food and Drug Administration. Issued: November 2018  

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 12 13 14 15 下一页 尾页 15/15/15
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇PERSERIS (risperidone) for exte.. 下一篇LUXTURNA(voretigene neparvovec-..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位